Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 12:14 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 601–624 of 2,449 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Implant Clear all

Conditions: Parkinson Disease, Movement Disorders
Interventions: Libra Deep Brain Stimulation System; Device
Lead sponsor: Abbott Medical Devices; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 136 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2016
U.S. locations: 15
States / cities: Loma Linda, California • Gainesville, Florida • Miami, Florida + 11 more

Conditions: Edentulous Jaw
Interventions: Eztetic dental implant; Device
Lead sponsor: ZimVie; Industry
Eligibility: 18 Years and older
Enrollment: 82 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2026
U.S. locations: 2
States / cities: Columbus, Ohio • Richmond, Virginia

Conditions: Hip Injuries, Tendon Injuries, Orthopedic Procedures
Interventions: Standard gluteus medius repair with Tapestry Biointegrative implant; Device
Lead sponsor: Ohio State University; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 3
States / cities: Columbus, Ohio • Westerville, Ohio

Conditions: Diabetes Mellitus Type 1
Interventions: Allogeneic Pancreatic Endocrine Cell Clusters; Biological
Lead sponsor: Seraxis; Industry
Eligibility: 18 Years to 65 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 2
States / cities: Philadelphia, Pennsylvania • Pittsburgh, Pennsylvania

Conditions: Non-small Cell Lung Cancer
Interventions: sunvozertinib, Pemetrexed+carboplatin; Drug
Lead sponsor: Dizal Pharmaceuticals; Industry
Eligibility: 18 Years and older
Enrollment: 324 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 15
States / cities: Glendale, California • Vallejo, California • Aurora, Colorado + 10 more

Conditions: Pacemaker Ddd, ICD
Interventions: CIED interrogation; Device
Lead sponsor: Edward Hospital; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Naperville, Illinois

Conditions: Kidney Failure, Chronic
Interventions: Biologic specimens; Other
Lead sponsor: University of Nebraska; Other
Eligibility: 19 Years and older
Enrollment: 43 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2017
U.S. locations: 1
States / cities: Omaha, Nebraska

Conditions: Diabetes Mellitus
Interventions: Well-controlled diabetic (WC), Poorly controlled diabetics (PC); Device
Lead sponsor: University of Minnesota; Other
Eligibility: 18 Years to 85 Years
Enrollment: 42 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2021
U.S. locations: 3
States / cities: Minneapolis, Minnesota • Houston, Texas • Seattle, Washington

Conditions: Enteral Nutrition, Feeding Tube Placement
Interventions: Not listed
Lead sponsor: Medtronic - MITG; Industry
Eligibility: 18 Years and older
Enrollment: 49 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Parkinson Disease
Interventions: SJM Infinity™ DBS IPG or SJM Brio™ DBS IPG system; Device
Lead sponsor: Abbott Medical Devices; Industry
Eligibility: 18 Years to 74 Years
Enrollment: 17 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2020
U.S. locations: 3
States / cities: Kendall, Florida • Miami, Florida • Albany, New York

Conditions: Tricuspid Valve Insufficiency, Right Heart Failure, Heart Failure
Interventions: Tricuspid valve repair or replacement, Medical management of tricuspid regurgitation; Procedure · Other
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 71 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2023
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Lower Extremity Surgery, Upper Extremity Surgery, Post-operative Pain
Interventions: Sciatic catheter left 0-1cm past needle tip vs. 5-6cm past needle tip; Procedure
Lead sponsor: University of California, San Diego; Other
Eligibility: 18 Years and older
Enrollment: 350 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 1
States / cities: San Diego, California

Conditions: Infertility, Female
Interventions: G-CSF, Saline; Drug
Lead sponsor: Center for Human Reproduction; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 129 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2013
U.S. locations: 1
States / cities: New York, New York

Conditions: Defibrillators, Implantable, Myocardial Infarction, Tachycardias, Ventricular
Interventions: ICD; Device
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 2,047 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2008
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Patients With Peripheral Intravenous Access Lines
Interventions: Ultrasound-guided peripheral intravenous access line placement, Landmark Approach to peripheral intravenous access line placement; Procedure
Lead sponsor: George Washington University; Other
Eligibility: 18 Years and older
Enrollment: 1,189 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: To Collect Information About Visual Outcomes and Participant Satisfaction
Interventions: Tecnis one-piece MF IOL, Crystalens AO; Device
Lead sponsor: Innovative Medical; Industry
Eligibility: 18 Years and older
Enrollment: 12 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2012
U.S. locations: 1
States / cities: Lake Villa, Illinois

Conditions: Lenses, Intraocular, Glistenings, Visual Quality
Interventions: Not listed
Lead sponsor: University of Utah; Other
Eligibility: Not listed
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2013
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Non-Proliferative Diabetic Retinopathy
Interventions: Single intravitreal injection of axitinib hydrogel implant followed by a mock (sham) injection procedure at Week 24, Intravitreal injection of axitinib hydrogel implant followed by a second intravitreal injection of the axitinib implant at Week 24, Sham/mock procedure of intravitreal injection followed by a second sham/mock procedure at Week 24; Drug · Other
Lead sponsor: Ocular Therapeutix, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 930 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Hagerstown, Maryland

Conditions: IUD, Contraceptive Implant, Contraception, Birth Control, Emergency Contraception
Interventions: Copper T-380 IUD, LNG IUD, Contraceptive implant Nexplanon, Depo-Provera; Drug · Device
Lead sponsor: University of Utah; Other
Eligibility: 15 Years to 45 Years · Female only
Enrollment: 270 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2021
U.S. locations: 1
States / cities: West Valley City, Utah

Conditions: Contraception
Interventions: Etonogestrel contraceptive implant with oral levonorgestrel, Levonorgestrel intrauterine device, Copper T380A intrauterine device; Device
Lead sponsor: University of Utah; Other
Eligibility: 18 Years to 35 Years · Female only
Enrollment: 306 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 2
States / cities: Salt Lake City, Utah • West Valley City, Utah

Conditions: Ventricular Tachycardia
Interventions: Sphere-9 Catheter with the Affera Mapping and Ablation System; Device
Lead sponsor: Medtronic Cardiac Ablation Solutions; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 260 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 7
States / cities: Littleton, Colorado • Indianapolis, Indiana • Manhasset, New York + 4 more

Conditions: Arrhythmia, Tachycardia, Ventricular, Ventricular Fibrillation
Interventions: SSR149744C; Drug
Lead sponsor: Sanofi; Industry
Eligibility: 21 Years and older
Enrollment: 153 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2007
U.S. locations: 1
States / cities: Bridgewater, New Jersey

Conditions: Heart Failure, Systolic, Left Bundle Branch Block
Interventions: Cardiac Resynchronization Therapy (CRT) implantation; Procedure
Lead sponsor: Emory University; Other
Eligibility: Not listed
Enrollment: 38 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2014
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Gingival Recession Localized Moderate, Dental Implant
Interventions: Zderm; Device
Lead sponsor: The University of Texas Health Science Center at San Antonio; Other
Eligibility: 18 Years to 89 Years
Enrollment: 68 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: San Antonio, Texas

Search by objective public record fields.

Deep Brain Stimulation to Treat Symptoms of Parkinson's Disease

A Clinical Study of the Eztetic Dental Implant System

Evaluation of Healing Following Open Gluteus Medius Repair With Biointegrative Implant

A Study of the Safety and Efficacy of Pancreatic Endocrine Cell Clusters Implanted Into the Omentum of Type 1 Diabetes Patients With Severe Hypoglycemia

A Study of DZD9008 Versus Platinum-Based Doublet Chemotherapy in Local Advanced or Metastatic Non-small Cell Lung Cancer (WU-KONG28)

Evaluation of CIED "Readers" for Disease Management

Arteriovenous Fistula Tissue Bank for Pre- and Post-Fistula Placement Specimens

Alveolar Bone Changes in Diabetes (ABCD) Study

Case Series to Evaluate the Identification of Anatomical Markers Using the KANGAROO™ Feeding Tube

IPG Replacement Study (PREFERENCE-H)

Treatment of Tricuspid Valve Regurgitation in Patients Undergoing Left Ventricular Assist Device Implantation Study

Perineural Catheter Insertion Distance for Continuous Peripheral Nerve Blocks

Effect of Colony Stimulating Factor on Implantation and Pregnancy Rates Following IVF (in Vitro Fertilization)

Risk of Life-threatening Heart Rhythm Disturbances in Siblings

Evaluate Initial Success Rate of Ultrasound Guided Versus Landmark Approach For Peripheral Intravenous Access

Prospective Evaluation of Visual Outcomes With Tecnis One-Piece Multifocal Intraocular Lenses Compared With Patients Previously Implanted With Crystalens Aspheric Optic (AO)

Impact of Glistenings in AcrySof Intraocular Lenses on Visual Quality

A Study to Evaluate the Efficacy and Safety of OTX-TKI (Axitinib Implant) in Participants With Non-Proliferative Diabetic Retinopathy

Quick Start of Highly Effective Contraception

Same Day Oral EC and Implant Initiation

Safety and Effectiveness of the Sphere-9™ Catheter and Affera™ Ablation System for the Treatment of Ventricular Tachycardia (Sphere VT)

Double Blind Placebo Controlled Dose Ranging Study of the Efficacy and Safety of SSR149744c 100 or 300 mg for the Prevention of ventrICular ARrhythmia-triggered Icd interventiOnS

Optimal Coronary Sinus Lead Implantation Using Intracardiac Impedography and Magnetic Resonance Imaging

Free Soft Tissue Grafts (FSTG) Using Autograft Palatal Donor Tissue vs. Xenograft Collagen Matrix (Zderm™)